Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Baby formula study reveals doctor prescribing habits

NCT ID NCT06318117

Knowledge-focused Sponsor: Mead Johnson Nutrition Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observed 41 infants aged 6 to 36 months who were given a rice-based infant formula (RIF). Researchers wanted to understand why pediatricians prescribe RIF during the first year of life, especially before 6 months of age. The study did not test any treatment but simply collected information from parents and doctors about real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

41 people

The number who actually took part.

Started

Mar 2024

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

120 infants will be recruited for this study, according to the following inclusion and non-inclusion criteria, including at least 60 infants who started the RIF before the age of 6 months.

Ages

6 to 36 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child aged between 6 and 36 months, * Child who has already consumed a RIF for at least one month, or still consuming a RIF, or who will benefit from taking a RIF, according to the pediatrician, * Legal representatives (parents/guardians) deemed capable of following the requirements of the protocol and have given their consent orally. Exclusion Criteria: * Child with a clinically relevant and significant abnormality in the medical history or on physical examination; * Child who has been hospitalized in a neonatology unit (due to prematurity, malformation or neonatal pathology), or born with a low birth weight (≤ 2,500 g); * For children not diversified at the time of starting RIF: mixed feeding with RIF and breast milk and/or infant formula based on cow's milk; * Child born to minor parent(s); * Infant or infant's family unable to comply with study protocol or procedures, in the judgment of the investigator; * Participation in any other clinical trial prior to inclusion; * Refusal of the Parents / legal representatives of the child, or who do not master the French language well enough to understand the information letter.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant formula are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant formula

Contacts and locations

Locations

  • Centre Hospitalier Universitaire de Nantes - Pediatric emergency department

    Nantes, Nantes, 44093, France

  • Centre Hospitalier d'Auxerre - Neonatology and pediatric emergency department

    Auxerre, Auxerre, 89011, France

  • Centre Hospitalier de Montauban - Pediatric Department

    Montauban, Montauban, France

  • Dr Christine REGIMBART - Private Practice

    Bécon-les-Granits, Becon-les-Granits, 49026, France

  • Dr Frederic Couttenier Private Practice

    Attiches, 59551, France

  • Dr Marta Nowak-Mohamed - Private Practice

    Vichy, Vichy, 03200, France

  • Dr. Amandine Blasquez Private Practice

    Libourne, 33500, France

  • Dr. Anne Cheve Private Practice

    Brest, 29200, France

  • Dr. Anne Sengier - Private Practice

    Le Havre, LE Havre, 76600, France

  • Dr. Karim Abada Private Practice

    Foix, 09017, France

  • Dr. Marc Sznajder Private Practice

    Paris, 75011, France

  • Dr. Nellie Houeto Private Practice

    Hyères, 83400, France

  • Dr. Piotr Gembara Private Practice

    Vichy, 03200, France

  • Dr. Sandra Brancato Private Practice

    Brignon, 30190, France

  • Elise Foy-Foulkes Private Practice

    Boulogne-Billancourt, 92100, France

  • Hôpital NOVO - Pediatric department

    Pontoise, Pontoise, 95300, France

  • Scm Les Pediatrices Du Pic St Loup

    Saint-Clément, DE Riviere, 34980, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.